References: Sodium valproate or carbamazepine for psychiatric disorders during pregnancy

  • Austin M-P, Highet Nthe Expert Working Group. Mental health care in the perinatal period: Australian clinical practice guideline. Melbourne: Centre of Perinatal Excellence; 2017. https://www.cope.org.au/health-professionals/health-professionals-3/review-of-new-perinatal-mental-health-guidelines/
  • Bromley R, Weston J, Adab N, Greenhalgh J, Sanniti A, McKay AJ, et al. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. Cochrane Database Syst Rev 2014;(10):CD010236. https://www.ncbi.nlm.nih.gov/pubmed/25354543
  • Chisolm MS, Payne JL. Management of psychotropic drugs during pregnancy. BMJ 2016;532:h5918. https://www.ncbi.nlm.nih.gov/pubmed/26791406
  • Harden CL, Pennell PB, Koppel BS, Hovinga CA, Gidal B, Meador KJ, et al. Management issues for women with epilepsy--focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2009;50(5):1247–55. https://www.ncbi.nlm.nih.gov/pubmed/19507305
  • McAllister-Williams RH, Baldwin DS, Cantwell R, Easter A, Gilvarry E, Glover V, et al. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017. J Psychopharmacol 2017;31(5):519–52. https://www.ncbi.nlm.nih.gov/pubmed/28440103
  • National Institute for Health and Care Excellence (NICE). Antenatal and postnatal mental health: clinical management and service guidance [cg192]. London: NICE; 2014 (updated 2020). https://www.nice.org.uk/guidance/cg192
  • Tomson T, Battino D, Bromley R, Kochen S, Meador K, Pennell P, et al. Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy. Epileptic Disord 2019;21(6):497–517. https://www.ncbi.nlm.nih.gov/pubmed/31782407
  • Viguera AC, Whitfield T, Baldessarini RJ, Newport DJ, Stowe Z, Reminick A, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007;164(12):1817–24; quiz 923. https://pubmed.ncbi.nlm.nih.gov/18056236/
  • Weston J, Bromley R, Jackson CF, Adab N, Clayton-Smith J, Greenhalgh J, et al. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Syst Rev 2016;11:CD010224. https://www.ncbi.nlm.nih.gov/pubmed/27819746